Économie

New York City Drug Companies Over Opioid Crisis

New York City Drug Companies Over Opioid Crisis

In both cases, Mr. de Blasio and his staff likened the efforts to litigation targeting tobacco companies, and suggested that the goals were similar, and that the goals were similar. The city’s top lawyer, Zachary W. Carter, acknowledged that the city would look to take legal action in cases “when the target is an industry that causes harm.” But he rejected the notion that the two suits of any new initiative in city government . “That’s really a coincidence of timing,” he said. Indeed, in 2000, under Mayor Rudolph W. Giuliani, the city sued the gun manufacturers and distributors claiming they failed to properly monitor the hands of criminals. The lawsuit was eventually dismissed. Mayor Michael R. Bloomberg had more luck with a 2006 lawsuit that focused on dealerships in the South than had been used in New York City crimes. Most of the dealers settled. New York is far from the first to take drugs to the crisis. Chicago did so in 2014 and its case is continuing; City counsels 10 million pages of documents and led by hundreds of interviews, according to a spokesman for the Chicago law department, Bill McCaffery.

In the years since, one of the following has been established in the field of medical care. heroin. Philadelphia and Delaware each filed lawsuits in recent days. A lawsuit filed by Oklahoma is expected to go to trial later this year. In New York State, The Simmons Hanly Conroy is based in the United States, Ill. The firm, which is representing localities in about 200 cases around the country, is representing New York City in its follows. “Paul J. Hanly, Jr., who leads the law firm’s new York office, said of the national trend. “We could be in a situation of a thousand or two thousand cases.”

Continue reading the main story

As opioids and heroin increasing number of lives , New York City has been slow to respond to the crisis. Last year Mr. de Blasio announced a plan to reduce opioid deaths through a combination of outreach, treatment and law enforcement. The final tally of overdose deaths was reported last month, with Mr. de Blasio saying that the most recent deaths in New York City from a drug overdose, most involving an opioid, as well as accidents and homicides. The lawsuit, filed Tuesday in the State Supreme Court in Manhattan, alleges that the opioid crisis is caused by the deceptive marketing of drugmakers, and by distributors bringing large amounts of prescription painkillers into the New York market. All of this has caused the city to spend millions of dollars on substance abuse treatment programs, hospital services, emergency medical services and law enforcement. The manufacturers named in the lawsuit include Purdue Pharma, Teva, Cephalon, Johnson & Johnson, Janssen, Endo, Allergan, Watson and various subsidiaries. The distributors include McKesson, Cardinal Health and AmerisourceBergen. “We maintain that the allegations made in these lawsuits against our company are baseless and unsubstantiated,” spokeswoman for Janssen Pharmaceuticals, Sarah Freeman, said in a statement. “Our actions in the marketing and promotion of our medicines have been appropriate and responsible.” A spokesman for Purdue Pharma, John Puskar, said the company was “deeply troubled by the prescription and illicit opioid abuse crisis, and is dedicated to being part of the solution,” and added that it “vigorously” denied the city’s allegations. Continue reading the main story

Post Comment